ABSTRACT
Electroconvulsive therapy (ECT) induces a prompt (acute) cardiovascular (CV) response. Electrical stimulus of the ECT and seizures induced by it produce marked cardiovascular responses by direct stimulation of cardiac centres in hypothalamus and indirectly by the generalization of seizure (Abrams,1997) . The acute CV responses in an unatropinised individual are an initial asystole followed by a transient tachycardia and increased blood pressure. Blood pressure (BP) responses generally parallel heart rate throughout the treatment. The BP drops sharply during the initial vagal, hypertonic phase and then rapidly increases upto 40% over baseline. The BP elevation is more when atropine premedication motor seizure modification, succinylcholine dose.
is given (Mu'lgaokar et al.,1985; Prudic et al.,1987) . More specifically, systolic blood pressure peaks during immediate poststimulus (ictal) period. These increase in systolic blood pressure is greater than diastolic blood pressure (Prudic et al.,1987) .
Rate-Pressure-Product(RPP), a product of heart rate and systolic blood pressure, is an index of myocardial oxygen consumption and is one such measure of CV response during ECT. RPP change during ECT have been described (Mayur et al.,1998a; Webb et al.,1990) . RPP increase by 30% to 140% during ECT induced seizure (Jones & Knight et al.,1981; Mulgaokar et al.,1985; Huang etal.,1989; Webb et al.,1990) . It reaches its maximum about 30 seconds after CARDIOVASCULAR RESPONSE TO E the ECT stimulus (Jones & Knight, 1981) . Use of atropine as premedication during ECT increase RPP response (Mayur et al.,1998b) . Postical RPP was significantly higher after threshold BLECT than threshold ULECT (Mayur etal., 1998a) . However, unilateral threshold ECT produced significantly lower RPP than unilateral suprathreshold and bilateral suprathreshold ECT conditions within the same group of patients (Gangadhar etal., 1999) .
Succinylcholine is a muscle relaxant, commonly used in ECT. By its depolarising properties it increases serum potassium levels and variably modifies peripheral motor convulsions. These factors can affect cardiovascular responses both directly and indirectly. It is likely that a more pronounced convulsive response contribuios to higher RPP, which was examined in this study.
MATERIAL AND METHOD

Patients :
Consenting consecutive patients referred for ECT (n=50; 31 males; Unilateral=25, Bilateral=25) formed the sample. Their mean ± SD age was 27.92±9.9 years and mean ± SD body weight 49.25±10.65 kilograms. Their diagnoses were schizophrenia (n=27), mania (n=4) and depression (n=19). After obtaining additional consent for this trial, they were part of the study at the second ECT session. All patients were right handed and continued to receive one or more psychotropic drugs, not lithium. None had cardiovascular clinical abnormalities or liver dysfunction (supported by biochemical liver function tests).
Anesthesia :
Patients were anesthetised with thiopentone (4 mg/kg) and atropine (0.65 mg). During the second ECT session, they were equally randomized to receive either 0.5 mg/kg or 1.0 mg/kg body weight of succinylcholine. Intermittent positive pressure ventilation with 100% oxygen was provided till resumption of spontaneous and regular breathing.
r & MOTOR SEIZURE MODIFICATION ECT administration :
ECT was administered using a computerized constant current (800mA) bidirectional brief pulse (1.25 msec width) device (NIVIQURE) with EFG monitoring (F 3 & F 4 referenced to linked mastoids). The ECT machine provides pulses at a rate of 125 pps. The total stimulus dose (mC) is adjusted by setting the stimulus train length (0.2-3.6s). The stimulus laterality was as prescribed by the referring psychiatrist. Standard bifrontotemporal and nondominant (right) D'Elia stimulus electrode positions were used for bilateral (BLECT) and right unilateral (ULECT) ECT patients respectively. ULECT patients received 2.5 times threshold stimulus and BLECT patients received 60 mC above the threshold. Motor seizure was monitored with the cuff above the right ankle. Last clonic movement on any part of the body was considered the end of motor seizure and unequivocal absence of epileptiform transients for more than five seconds on both channels was considered as the end of the EEG seizure (Gangadhar et al.,1995) .
Cardiovascular monitoring :
Online cardiovascular and pulse oximetric parameters were monitored using Cardiocap-ll. Blood pressure and heart rate were recorded before and after induction of anesthesia, 20 seconds poststimulus (ictal), postical and after spontaneous resumption of respiration.
Assessments :
One independent investigator (MN) was responsible for recruiting and randomising patients to two different doses of succinylcholine. The anaesthetist (Rater -A; SKS) and one other psychiatrist (Rater -B; SESM) who were unaware of the dose of succinylcholine, independently rated the extent of motor seizure modification using a standardized scale (Appendix). A score of less than three and 3 or more on the scale were operationally defined as poor' and good' modifications respectively Rater-B noted the motor and EEG seizure durations using the digital counter in the ECT machine. Two milliliters N. MURALI et al.
of blood was drawn from the patients before the administra'tion of anesthetic agents and immediately after ECT for the estimation of the serum potassium levels. Serum potassium assays on coded samples were performed without knowledge of patient data(RC).
Statistics :
Independent sample t-test and chi-square test were used to compare variables of patients with' low dose' (0.5 mg/kg) and 'high dose' (1mg/ kg). Change in serum potassium levels from preto post-ECT occasions was examined using paired t-test. Interrater reliability on the modification score between raters (Rater-A and Rater-B) was assessed using Kappa correlation. For further analyses, scores by the psychiatrist (Rater-B) were used. Two way repeated measure analysis of variance (RMANOVA) was used to examine the change of RPP across five occasions (within-subject factor) with 'poor'/ 'good' modification as between-subject factor. RMANOVA was repeated with succinylcholine dose and with laterality as between-subject factors separately. Pearson's correlation was applied to determine factors influencing RPP in each of the five occasions. Multiple, step-wise, linear regression was used to determine the factors influencing ictal and postictal RPP for entire patient sample. The probability (alpha) was fixed at <0.05.
Results
:
Socio-demographic and ECT variables were comparable between patients who received low 1 and high' dose succinylcholine (Table-1 ). The two raters showed good agreement for the scores of extent of modification (Kappa Coefficients.88) as well as for recorded scores of 'good' and poor modification (Kappa Coefficients.91) respectively. The modification score was higher in the 1 mg/kg group. Also only 3 (12%) patients in this group had 'poor' modification as against 17 (68%) of the 0.5 mg/kg group. Serum potassium levels (mean±SD meq/L) significantly rose from pre-(4.34±0.2) to post-(4.58±0.3) ictal occasion in the patients with succinylcholine of 1 mg/kg (t=4, df=23, p=0.001). No such changes were noted in the ECT session with 0.5 mg/kg (pre=4.53±0.3; post=4.57±0.3 : t=0.57, df=23, p=0.57).
RPP changed significantly over the five occasions, being highest in ictal recording (Table. 2). Neither, succinylcholine dose, nor stimulus laterality, nor extent of modification (as between-subject factors) affected RPP differentially (Table. 2). Ictal RPP positively correlated with post-anaesthesia RPP, ECT stimulus dose, and seizure threshold, seizure durations (both motor and EEG) but did not correlate with motor seizure modification scores. Likewise, postictal RPP correlated with threshold and actual ECT stimulus dose but not with motor seizure modification scores. (Table. 3).
In view of multiple correlations, ictal and postictal RPP as dependent variables, were examined in two separate multiple, stepwise, linear regression models. Age, threshold, actual N. MUF stimulus dose, stimulus laterality, postanaesthesia RPP, extent of modification scores, EEG and motor seizure durations were the independent variables. Postanaesthesia RPP (fi=0.54, t=4.9, p=0.001), stimulus laterality (fl=-0.37, t=3.4, p=0.01) and motor seizure duration (G=0.31, t=2.9, p=0.006) explained respectively 24%, 13% and 10% of variance in ictal RPP. Unilateral ECT and longer motor seizure duration were associated with higher ictal RPP. Actual stimulus dose used ((1=0.36, t=2.7, p=0 .009) explained 13% of variance in postictal RPP; higher stimulus was associated with higher postictal RPP. Motor seizure modification scores (continuous or dichotomous) were not significant in both regressions.
DISCUSSION
In this study most of the patients with 1 mg/kg succinylcholine had deeper muscle relaxation and good motor seizure modification. Succinylcholine being a depolarising muscle relaxant, mobilizes intracellular potassium to extracellular compartment. Significant increase in serum potassium levels from pre-to post-ECT occasion was seen only in patients with high' dose succinylcholine, which validates the dose effect. However none had clinical complications, such as cardiac arrhythmia or prolonged apnea. Succinylcholine dose used in this study did not produce differential cardiovascular responses (Table. 2).
Twenty patients had 'poor' motor seizure modification. However, modification status did not affect RPP measures (Table. 2). This observation is contrary to the belief that the violent seizures may increase myocardial stress. Subjects of this study had no cardiovascular problems, and were relatively young. Thus findings of this study may not apply to elderly or cardiac compromised patients.
.There was no differences in RPP between BLECT and ULECT patients receiving suprathreshold stimulus. However, Mayur et al. (1988a) reported differences between ULECT and BLECT patients both receiving threshold LI et al. stimulus. Similar observations have been reported recently (Gangadhar et al.,1999) in an intraindividual crossover design. However in the multiple regression model, unilateral ECT was associated with higher ictal RPP.
As the dose of succinylcholine and extent of motor seizure modification did not influence RPP (ictal or postictal), it can be argued that the observed effects on RPP were mediated by stimulus dose and seizure duration. Thus RPP response may be window to cerebral mechanisms during ECT. RPP response may hence, be a tool to understand the therapeutic or adverse effects of ECT. Some trends suggest that higher RPP during ECT may be associated with better therapeutic potency (Webb et al.,1990) . RPP holds promise as a noninvasive, but indirect measure of CNS effects during ECT to understand neurophysiological mechanisms of ECT. Bilateral motor convulsions and they are equal in intensity in both cuffed and uncuffed limbs. 3
APPENDIX
Bilateral motor convulsions and the intensity is more in cuffed limb when compared to corresponding uncuffed limb. 4
Motor convulsions in cuffed limb and face. 5
Motor convulsions only in cuffed limb.
